Stock screener

LNTH

Conviction 84HealthcareScan · Thu, Jun 25, 2026
LNTH$108.99+3.95%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 878.42K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Lantheus Holdings, Inc.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.lantheus.com ↗
Price108.99
Change+3.95%
Gap+1.27%
Rel volume1.18×
Avg volume916.85K
Avg $ vol93.93M
SMA 20102.41
SMA 5094.69
SMA 20071.91
Price vs 50+15.11%
Price vs 200+51.57%
MA stackbullish
50/200 cross—
Supertrendup · 97.49
RSI (14)70
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D100 / 84
ADX (14)43
+DI / −DI28 / 11
RSI divergence—
MACD divergence—
ATR %+3.07%
ADR %3.18%
52w high108.99
52w low50.11
From 52w high+0.00%
Above 52w low+117.50%
New 52w highYes
SqueezeOff
Bollinger width12.52%
%B1.01
Donchian pos99.79%
Donchian high109.02
Donchian low95.00
AVWAP (52w high)107.98
vs AVWAP high+0.94%
AVWAP (52w low)66.83
vs AVWAP low+63.08%
OBV trendFlat
Chaikin MF (20)-0.01
Today vs 20d1.18×
Avg vol (14d)878.41K
Avg vol (20d)916.85K
Avg $ vol (20d)93.93M
Market cap7.1B
RS 3m (vs SPY)+28.97%
RS 6m (vs SPY)+51.32%
RS line new highNo
Trend template8/8
Technical rank91.7
1 week+5.62%
1 month+8.92%
3 months+44.11%
6 months+60.26%
1 year+34.64%
YTD+62.02%
P/E30.38
P/B5.85
P/S4.60
P/FCF20.58
EPS3.41
Div yield0.00%
ROE19.27%
ROA9.95%
Debt/Eq0.46
Current2.83
EV/EBITDA18.79
Gross margin61.10%
Net margin15.15%
Rev growth0.50%
EPS growth-25.25%
Price target105.15
Target upside-3.52%
Analyst ratingBuy
Institutional123.63%
Ent. value7.16B
Revenue377.33M
Net income118.42M
Gross profit230.92M
Free cash flow344.8M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out65.11M
Employees1.19K
ListedThu, Jun 25, 2015
Free float63.52M
Float %97.8%
Short interest5.48M
Days to cover4.3d
Short volume50.5%
Squeeze score49 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$1.09 · 4 est
Last EPS vs est$1.21 vs $1.02
Last surprise+18.6% beat
Setup gradeA
Conviction84 / 100
Pattern quality—
Tech rank91.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance106.00
Support93.33
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LNTH · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-13
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-07
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-08
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-28
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in LNTH · 6 buys · 2 sells

InsiderSideShares
Heino Mary Anne
Executive Chair and CEO · Common Stock · 2026-05-14
Other—
Ber Gerard
Director · Common Stock · 2026-05-14
Tax381
Heino Mary Anne
Executive Chair and CEO · Common Stock · 2026-05-14
Tax1.23K
Baylor-Henry Minnie
Director · Common Stock · 2026-05-14
Grant4.14K
Thrall James H
Director · Common Stock · 2026-05-14
Grant4.14K
Ber Gerard
Director · Common Stock · 2026-05-14
Grant4.14K
EASTLAND JULIA MARIE
Director · Common Stock · 2026-05-14
Grant4.14K
Maeusli Heinz Christoph
Director · Common Stock · 2026-05-14
Grant4.14K
Baylor-Henry Minnie
Director · Common Stock · 2026-05-14
Other—
Morrow Phuong Khanh
Director · Common Stock · 2026-05-14
Grant4.14K

SEC filings

EDGAR filings in LNTH

EDGAR →

No recent SEC filings on file for LNTH.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.